GV (Google Ventures)

Healthcare innovation was a buzz last week as HLTH Inc. USA took over. GV partners and portfolio company founders joined panels exploring how technology, data, and new business models are transforming care delivery and access. 🎤 GV General Partners Frederique Dame and Ben Robbins joined discussions on healthcare investment and innovation. 🩺 Zachary Ziegler of OpenEvidence, Joanna Strober of Midi Health, Hassan Zahir of Medallion Dr Maneesh Jain of Mirvie, and Dr Chris Mansi of Viz.ai shared insights from the frontlines of AI, women’s health, automation, and patient care. The highlight was our HLTH After Dark party at Nobu Restaurants where we enjoyed some fresh air, cocktails and magic tricks. As always we left proud to witness GV partners and founders lead the conversations that drive the future of healthcare forward.

American Naval Autonomy with Global Ambitions Blue Water Autonomy Inc. founder CEO Rylan Hamilton (US Navy veteran) sat down with GV Managing Partner Dave Munichiello (US Air Force veteran) to share his vision for scaling the company’s production capabilities and its impact on the future of American Naval autonomy for the open ocean. Part of his vision includes the company’s new partnership with Louisiana-based Conrad Shipyard, a strategic collaboration that will help bring Blue Water’s autonomous ship technology beyond U.S. waters and onto the global stage. Hear their full conversation on our blog: https://lnkd.in/eUiy9W4M

Your style, decoded. The Business of Fashion named Daydream one of 17 AI fashion startups to watch, spotlighting their personalized chat-based shopping agent as a standout service that makes finding what fits you easier than ever. Their chat-based shopping agent takes the anxiety and guesswork out of finding your personal style, bringing personalized results mined from thousands of brands. We’re proud to back companies building AI that makes everyday experiences smarter—and more stylish. Congrats to the Daydream team!

Whether advancing AI, expanding access to care, or streamlining how businesses work, these U.S.-based GV portfolio companies are driving meaningful change. We’re proud to see them named in LinkedIn’s Top Startups of 2025. 🧠 Thinking Machines Lab 🚺 Midi Health ⚖️ Harvey 🗂️ Medallion Congratulations to these founders and teams building the next generation of category-defining companies. The future is taking shape—fast. 

OpenEvidence is revolutionizing the doctor experience in America. Right now, doctors are stretched thin and overwhelmed with information. The U.S. has about 1 million active physicians serving a population of 340 million, and medical knowledge is estimated to double every five years. Between emerging research and patient volume, it’s hard for doctors to keep up and suggest the best treatment plans for their patients. That’s where OpenEvidence comes in. They are building medical AI models trained only on curated databases of trusted and peer-reviewed medical literature. Their app helps doctors make faster, more informed decisions at the point of care. This year alone, more than 100 million Americans will be treated by a doctor using OpenEvidence. We’re proud to lead their Series C round. With this funding, the team will train new medical AI models, scale compute, and continue building toward medical superintelligence. A huge congrats to Daniel Nadler, Zachary Ziegler, and the entire OE team on this milestone! 

Today’s healthcare system is backed up by physician shortages, costly appointments, and long waits for care, resulting in delayed treatment and diminished outcomes for patients. High-quality, timely care shouldn’t be a luxury. Counsel Health is working to make it the standard. Counsel Health is an asynchronous care platform that leverages AI and expert physicians to deliver care and answers faster. Patients get the timely, high-quality care they need without the friction of traditional healthcare systems. Their platform has already achieved 33% fewer ER visits compared to traditional medical advice services. We’re proud to back the Counsel Health team in their Series A as they expand access to physician-led, messaging-based care and reimagine how patients connect with doctors. Congratulations to the team; welcome to GV!

Hair loss has touched nearly everyone, but real innovation hasn’t—until now. Pelage Pharmaceuticals is developing a treatment that reactivates dormant hair follicle stem cells to restart hair growth. The product could potentially be a first-in-class solution for individuals experiencing hair loss. With their new Series B funding, Pelage will advance its lead program, PP405, toward Phase 3 trials in 2026. Not many have tackled hair loss with new science, and we’re inspired by Daniel Gil, Christina Weng MD, William Lowry, Dr. Heather Christofk, Dr. Michael Jung pharma, and the Pelage team for doing exactly that, and for moving the field forward with rigor and innovation. 

We’re excited to see TIME name several GV portfolio companies and their products as some of the Best Inventions of 2025. From healthcare to audio to fashion and beyond, these teams are redefining their industries with groundbreaking innovation and design. 🩺 OpenEvidence 🧑🦲 Pelage Pharmaceuticals' PP405 🤰 Mirvie’s Encompass 🎧 Nothing Headphone (1) 🖥️ Warp’s Agentic Development Environment (ADE) 🛍️ Daydream These teams continue to prove that curiosity paired with dedication leads to meaningful breakthroughs. Read the full list here: https://lnkd.in/gjaB3q_7

Proud to support the Typeface team as they debut their first Signal Report. It highlights how AI is reshaping marketing across all levels: demand is rising, agency spend is shifting, and a majority of AI adoption projects are still in pilot mode. Read the team’s full analysis: http://bit.ly/4nsLJKC